# FDA Inspection 1209015 - BPC Plasma Inc - May 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/bpc-plasma-inc/291a957e-a92a-4cfd-8c28-cc7243add661
Source feed: FDA_Inspections

> FDA Inspection 1209015 for BPC Plasma Inc on May 17, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209015
- Company Name: BPC Plasma Inc
- Inspection Date: 2023-05-17
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1209015 - 2023-05-17](https://www.keypedia.com/records/fda_inspections/bpc-plasma-inc/d2654de0-a239-44a4-9716-0004754ae1d7)
- [FDA Inspection 1052706 - 2018-05-10](https://www.keypedia.com/records/fda_inspections/bpc-plasma-inc/82a2b88e-37d2-4054-828a-5a7391962d00)

Company: https://www.keypedia.com/companies/bpc-plasma-inc/12404aac-005c-44ef-a40e-3902aa65f14a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d